Your browser doesn't support javascript.
loading
Assessing the utility of molecular diagnostic classification for cancers of unknown primary.
Moore, Elle C; Blobe, Gerard C; DeVito, Nicholas C; Hanks, Brent A; Harrison, Michael R; Hoimes, Christopher J; Jia, Jingquan; Morse, Michael A; Jayaprakasan, Parvathy; MacKelfresh, Andrew; Mulder, Hillary; Hockenberry, Adam J; Zander, Alia; Stumpe, Martin C; Michuda, Jackson; Beauchamp, Kyle A; Perakslis, Eric; Taxter, Timothy; George, Daniel J.
Afiliação
  • Moore EC; Tempus Labs, Inc, Chicago, Illinois, USA.
  • Blobe GC; Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • DeVito NC; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina, USA.
  • Hanks BA; Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Harrison MR; Center for Cancer Immunotherapy, Duke University Medical Center, Durham, North Carolina, USA.
  • Hoimes CJ; Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Jia J; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina, USA.
  • Morse MA; Center for Cancer Immunotherapy, Duke University Medical Center, Durham, North Carolina, USA.
  • Jayaprakasan P; Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • MacKelfresh A; Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, North Carolina, USA.
  • Mulder H; Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Hockenberry AJ; Center for Cancer Immunotherapy, Duke University Medical Center, Durham, North Carolina, USA.
  • Zander A; Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, North Carolina, USA.
  • Stumpe MC; Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Michuda J; Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Beauchamp KA; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.
  • Perakslis E; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.
  • Taxter T; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.
  • George DJ; Tempus Labs, Inc, Chicago, Illinois, USA.
Cancer Med ; 12(19): 19394-19405, 2023 10.
Article em En | MEDLINE | ID: mdl-37712677
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Primárias Desconhecidas / Segunda Neoplasia Primária Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Primárias Desconhecidas / Segunda Neoplasia Primária Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos